In ovarian cancer, circITGB6 directly interacts with IGF2BP2 and FGF9 mRNA, stabilizing FGF9 mRNA and inducing TAM polarization towards the M2 phenotype, increasing ovarian cancer’s resistance to cisplatin594 (Fig. 5). The gene discussed is IGF2BP2; the disease is ovarian carcinoma.